Please read these conditions carefully before using this site. By using this site, you signify your assent to the following terms and conditions of use without limitation or qualification. In particular, you consent to the use of all cookies on this website for the purposes described in the terms of use. If you do not agree to these terms or to the use of cookies as described below, do not use this site. AllianceBernstein may at any time revise these terms of use. You are bound by any such revisions and should therefore periodically visit this page to review the then current terms of use to which you are bound. This site is for informational purposes and does not constitute an offer to sell or a solicitation of an offer to buy any security which may be referenced herein.

This site is solely intended for use by professional/institutional investors and institutional-investment industry consultants.

Do you wish to continue?

Chris Brigham, CFA

Senior Research Associate

6 Years at AB|14 Years of Experience

Chris Brigham is a Private Client Senior Research Associate at Bernstein. He joined Bernstein in 2018 as a member of the US Portfolio Strategy team. Prior to Bernstein, he worked in finance and strategy for EpiBone, a biotechnology startup. He has previously worked as a research analyst at Longview Asset Management and Tiresias Capital (Omni Partners) and as an event-driven analyst and trader at Bank of America Merrill Lynch. Chris earned his MBA from Columbia Business School, where he completed the Value Investing Program, and graduated Phi Beta Kappa with a BA in Economics from Claremont McKenna College. He completed the General Course at the London School of Economics and is a CFA charterholder. Location: New York

Published Work